UPDATED May 22, 2024
Discover U.K. Pharmaceuticals & Biotech Growth Stocks that are on the FTSE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TRX | UK£0.62 | 0.8% | 21.6% | UK£43.7m | UK£1.20 | PS1.9x | E133.0% | n/a | ||
SAR | UK£0.33 | -12.8% | -71.7% | UK£35.1m | UK£1.76 | PB84.1x | E117.2% | n/a | ||
FUM | UK£0.39 | 0.9% | -5.0% | UK£118.3m | UK£1.26 | PS38.2x | E111.8% | n/a | ||
ONC | UK£0.26 | 4.1% | -31.1% | UK£18.9m | n/a | PS16.4x | E107.2% | n/a | ||
OXB | UK£3.29 | -0.8% | -25.0% | UK£328.5m | UK£4.30 | PS3.7x | E100.4% | n/a | ||
STX | UK£0.021 | 10.8% | -69.4% | UK£16.0m | n/a | PS1.6x | E92.7% | n/a | ||
LLAI | UK£0.18 | -14.0% | -56.5% | UK£5.7m | UK£2.20 | PS156.9x | E88.7% | n/a | ||
BVX | UK£0.11 | -4.3% | -15.4% | UK£9.1m | n/a | PB3.2x | E63.8% | n/a | ||
DPH | UK£38.66 | 0.2% | 32.4% | UK£4.4b | UK£37.59 | PS5.8x | E62.5% | 0% | ||
DXRX | UK£1.28 | 15.9% | 51.8% | UK£107.7m | UK£1.67 | PS4.5x | E62.5% | n/a | ||
AREC | UK£1.59 | 21.0% | -37.8% | UK£48.5m | UK£5.04 | PS10.6x | E49.1% | n/a | ||
APH | UK£0.35 | 0% | -43.6% | UK£190.0m | n/a | PS1.1x | E47.8% | 0% | ||
EAH | UK£1.16 | -1.7% | 2.2% | UK£78.6m | UK£1.89 | PB1x | E46.3% | 0% | ||
SNG | UK£0.071 | 23.8% | -17.1% | UK£14.4m | n/a | PB0.9x | E40.6% | n/a | ||
INDV | UK£13.25 | -2.0% | -11.0% | UK£1.8b | UK£24.41 | PE455.1x | E34.7% | 0% | ||
TCF | UK£0.0075 | 0% | -80.0% | UK£3.2m | n/a | PS3.8x | E31.9% | n/a | ||
ONT | UK£1.09 | -2.4% | -57.0% | UK£938.5m | UK£1.98 | PS5.5x | E24.0% | n/a | ||
GNS | UK£18.68 | -0.6% | -25.8% | UK£1.2b | UK£27.78 | PE36.7x | E21.5% | 1.7% | ||
HCM | UK£3.13 | -7.1% | 52.3% | UK£2.7b | UK£4.44 | PE33.7x | E18.7% | n/a | ||
HIK | UK£19.39 | -2.2% | 5.8% | UK£4.3b | UK£22.93 | PE28.8x | E16.0% | 2.9% | ||
OCTP | UK£0.0018 | 16.1% | -82.9% | UK£2.0m | n/a | PB1x | E15.1% | n/a | ||
AZN | UK£123.60 | 1.6% | 6.2% | UK£191.6b | UK£133.35 | PE38.5x | E14.6% | 2.0% | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
GSK | UK£17.89 | 0.3% | 29.2% | UK£72.9b | UK£20.32 | PE16.3x | E12.2% | 3.2% |